|
|
|
|
Highly Successful Retreatment With LDV/SOF in HCV Gt-1 Patients Who Failed Short Course LDV/SOF-Based Therapy:
The NIH SYNERGY Trial
|
|
|
Reported by Jules Levin
AASLD 2015 Nov 13-17 San Francisco
Eleanor Wilson1,2, Sarah Kattakuzhy1, Zayani Sims1, Mary McLaughlin3, Angie Price1, Hongmei Mo4, Anu Osinusi4, Henry Masur2, Anita Kohli5, Shyam Kottilil1
1Institute of Human Virology, University of Maryland School of Medicine, Baltimore, MD; 2Critical Care Medicine Department and 3National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD; 4Gilead Sciences, Inc., Foster City, CA; 5St. Joseph's Hospital and Medical Center, Phoenix, AZ
|
|
|
|
|
|
|